Natural Capsules profit and loss

Latest FY26

Revenue: ₹187cr+10.6% on FY25
EBITDA: −₹1.6cr₹17.5 cr in FY25
Net profit: −₹24.7cr₹0.6 cr in FY25
EPS: −₹23.84₹0.22 in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025

Expenses
	191	187	169
	3.7	1.7	0.7
	194	189	170
	109	103	86.9
	−3.8	−0.9	−2.0
	22.0	21.0	14.1
	13.4	10.9	6.3
	17.3	17.1	9.1
	64.8	65.4	52.7
	222	217	167
	−0.8	−1.6	17.5
	−18.0	−18.7	8.4
Profit
	−27.7	−27.9	2.8
	−27.7	−27.9	2.8
	4.2	3.6	1.2
	−7.1	−6.9	0.9
	−2.9	−3.3	2.2
	−24.8	−24.7	0.6
	−24.8	−24.7	0.6
	−0.0	−0.0	−0.4
	−24.8	−24.7	0.2
	—	−17.1	—
	—	−7.6	—
Per share
	−₹24.01	−₹23.84	₹0.22
	−₹23.95	−₹23.78	₹0.22
Other comprehensive income — detail
	—	−0.0	−0.4
	—	−0.0	—
	—	0.0	0.4
	—	−17.1	—
	—	−7.6	—
Per share — as-filed variants
	−₹24.01	−₹23.84	₹0.22
	−₹23.95	−₹23.78	₹0.22
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	86.0	84.9	84.3
	45.1%	45.3%	49.8%
Adjusted (ex-exceptional items) — derived
	−27.7	−27.9	2.8
	−24.8	−24.7	0.6
	−₹24.01	−₹23.84	₹0.22

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NATCAPSUQ₹136.44

Natural Capsules Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersNECLIFE AAREYDRUGS BALPHARMA ALPA KREBSBIO MEDICAMEQ MEDICO VINEETLABMcap ₹142 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	169.2	187.2	190.7
Other Income	0.7	1.7	3.7
Total Income	169.9	188.9	194.4
Expenses
+ Cost of Materials Consumed	86.9	103.2	108.6
+ Changes in Inventories	-2.0	-0.9	-3.8
+ Employee Benefit Expense	14.1	21.0	22.0
+ Finance Costs	6.3	10.9	13.4
+ Depreciation & Amortisation	9.1	17.1	17.3
+ Other Expenses	52.7	65.4	64.8
Total Expenses	167.1	216.9	222.1
EBITDA	17.5	-1.6	-0.8
EBIT	8.4	-18.7	-18.0
Profit
PBT before Exceptional Items	2.8	-27.9	-27.7
Pretax Income	2.8	-27.9	-27.7
+ Current Tax	1.2	3.6	4.2
+ Deferred Tax	0.9	-6.9	-7.1
Tax Expense	2.2	-3.3	-2.9
Net Income	0.6	-24.7	-24.8
+ Net Income — Continuing Ops	0.6	-24.7	-24.8
+ Other Comprehensive Income	-0.4	-0.0	-0.0
Total Comprehensive Income	0.2	-24.7	-24.8
Net Income to Common	—	-17.1	—
Minority Interest	—	-7.6	—
Per Share
Basic EPS	0.22	-23.84	-24.01
Diluted EPS	0.22	-23.78	-23.95
Other Comprehensive Income — detail
+ Other Comprehensive Income	-0.4	-0.0	—
+ Items NOT to be Reclassified to P&L	—	-0.0	—
+ Tax on Items NOT to be Reclassified	0.4	0.0	—
Comprehensive Income — Owners of Parent	—	-17.1	—
Comprehensive Income — Non-controlling Interests	—	-7.6	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.22	-23.84	-24.01
Diluted EPS — Continuing Operations	0.22	-23.78	-23.95
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	84.3	84.9	86.0
Gross Margin %	49.82	45.33	45.09
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	2.8	-27.9	-27.7
Net Income Adj (tax-effected)	0.6	-24.7	-24.8
EPS Adj	0.22	-23.84	-24.01
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00
Filed Debt Equity	40.00	—	—
Paid Up Equity Capital	10.3	10.4	10.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.